Christopher Dostal

4PUBLICATIONS
10CO-AUTHORS
Electrical energy generation (incl. renewables, excl. photovoltaics)Neurology and neuromuscular diseasesMedical infection agents (incl. prions)Human impacts of climate change and human adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 12, 2025
The sodium/glucose cotransporter 2 inhibitor empagliflozin is a pharmacological chaperone of cardiac Nav1.5 channels.

Jakob Sauer, Jessica Marksteiner, Martin Hohenegger

|Aug 11, 2025
Inhibition of tenascin C rescues abnormally reduced Na currents in dystrophin-deficient ventricular cardiomyocytes.

Jessica Marksteiner, Jakob Sauer, Martin Hohenegger

|Dec 15, 2023
Empagliflozin treatment rescues abnormally reduced Na+ currents in ventricular cardiomyocytes from dystrophin-deficient mdx mice.

Jakob Sauer, Jessica Marksteiner, Elena Lilliu

|Aug 03, 2021
Remote Ischemic Perconditioning Ameliorates Myocardial Ischemia and Reperfusion-Induced Coronary Endothelial Dysfunction and Aortic Stiffness in Rats.

Petra Lujza Szabó, Christopher Dostal, Patrick Michael Pilz

Pageof 1

Frequent Collaborators

3 joint publications

Bruno K Podesser

3 joint publications

Hannes Todt

3 joint publications

Attila Kiss

3 joint publications

Xaver Koenig